Value of HCC-MELD score in patients with hepatocellular carcinoma undergoing liver transplantation

Gian Piero Guerrini, Domenico Pinelli, Elena Marini, Vittorio Corno, Michela Guizzetti, Marco Zambelli, Alessandro Aluffi, Lisa Lincini, Stefano Fagiuoli, Alessandro Lucianetti, Michele Colledan

Research output: Contribution to journalArticle

Abstract

Context: Liver transplantation (LT) is considered the ideal therapy for patients with hepatocellular carcinoma (HCC) having cirrhosis but the shortage of liver donors and the risk of dropout from the wait list due to tumor progression severely limit transplantation. A new prognostic score, the HCC-model for end-stage liver disease (HCC-MELD), was developed by combining a-fetoprotein (AFP), MELD, and tumor size, to improve risk stratification of dropout in patients with HCC. Objectives: In this study, we investigated the ability of the HCC-MELD score in predicting the posttransplant for patients fulfilling Milan criteria (MC). Design: Two hundred patients with stage II tumor were retrospectively reviewed from a total of 1290 transplants performed at our institution from October 1997 through April 2015. Cox regression analysis was performed to identify the prognostic factors impacting the posttransplant survival. Results: Overall survival at 1, 5, and 10 years was 89.3%, 71.1%, and 67.2%, whereas disease-free survival was 86.4%, 66.5%, and 52.4%, respectively. Multivariate analysis showed HCC-MELD score (hazard ratio [HR] 39.6, P < .001) and microvascular invasion (HR 2.41, P = .002) to be independent risk factors for recurrence, whereas HCC diameter (HR 1.15, P = .041), HCC-MELD (HR 15.611, P = .006), and grading (HR 2.17, P = .03) proved to be predictive factors of poor overall survival. Conclusion: Our study showed the validity of the HCC-MELD equation in the evaluation of patients undergoing LT for HCC. This score offers a reliable method to assess the risk of waiting list dropout and predict posttransplantation outcomes.

Original languageEnglish
Pages (from-to)63-69
Number of pages7
JournalProgress in Transplantation
Volume28
Issue number1
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Liver Transplantation
Hepatocellular Carcinoma
Survival
Fetal Proteins
Neoplasms
End Stage Liver Disease
Aptitude
Patient Dropouts
Waiting Lists
Liver Cirrhosis
Disease-Free Survival
Multivariate Analysis
Transplantation
Regression Analysis
Tissue Donors
Transplants
Recurrence

Keywords

  • HCC-MELD
  • Hepatocellular carcinoma
  • Liver transplantation
  • Liver tumor
  • MELD
  • Milan criteria

ASJC Scopus subject areas

  • Transplantation

Cite this

Guerrini, G. P., Pinelli, D., Marini, E., Corno, V., Guizzetti, M., Zambelli, M., ... Colledan, M. (2018). Value of HCC-MELD score in patients with hepatocellular carcinoma undergoing liver transplantation. Progress in Transplantation, 28(1), 63-69. https://doi.org/10.1177/1526924817746686

Value of HCC-MELD score in patients with hepatocellular carcinoma undergoing liver transplantation. / Guerrini, Gian Piero; Pinelli, Domenico; Marini, Elena; Corno, Vittorio; Guizzetti, Michela; Zambelli, Marco; Aluffi, Alessandro; Lincini, Lisa; Fagiuoli, Stefano; Lucianetti, Alessandro; Colledan, Michele.

In: Progress in Transplantation, Vol. 28, No. 1, 01.03.2018, p. 63-69.

Research output: Contribution to journalArticle

Guerrini, GP, Pinelli, D, Marini, E, Corno, V, Guizzetti, M, Zambelli, M, Aluffi, A, Lincini, L, Fagiuoli, S, Lucianetti, A & Colledan, M 2018, 'Value of HCC-MELD score in patients with hepatocellular carcinoma undergoing liver transplantation', Progress in Transplantation, vol. 28, no. 1, pp. 63-69. https://doi.org/10.1177/1526924817746686
Guerrini, Gian Piero ; Pinelli, Domenico ; Marini, Elena ; Corno, Vittorio ; Guizzetti, Michela ; Zambelli, Marco ; Aluffi, Alessandro ; Lincini, Lisa ; Fagiuoli, Stefano ; Lucianetti, Alessandro ; Colledan, Michele. / Value of HCC-MELD score in patients with hepatocellular carcinoma undergoing liver transplantation. In: Progress in Transplantation. 2018 ; Vol. 28, No. 1. pp. 63-69.
@article{48597ecda26b4f66b63e1687c4fa41fc,
title = "Value of HCC-MELD score in patients with hepatocellular carcinoma undergoing liver transplantation",
abstract = "Context: Liver transplantation (LT) is considered the ideal therapy for patients with hepatocellular carcinoma (HCC) having cirrhosis but the shortage of liver donors and the risk of dropout from the wait list due to tumor progression severely limit transplantation. A new prognostic score, the HCC-model for end-stage liver disease (HCC-MELD), was developed by combining a-fetoprotein (AFP), MELD, and tumor size, to improve risk stratification of dropout in patients with HCC. Objectives: In this study, we investigated the ability of the HCC-MELD score in predicting the posttransplant for patients fulfilling Milan criteria (MC). Design: Two hundred patients with stage II tumor were retrospectively reviewed from a total of 1290 transplants performed at our institution from October 1997 through April 2015. Cox regression analysis was performed to identify the prognostic factors impacting the posttransplant survival. Results: Overall survival at 1, 5, and 10 years was 89.3{\%}, 71.1{\%}, and 67.2{\%}, whereas disease-free survival was 86.4{\%}, 66.5{\%}, and 52.4{\%}, respectively. Multivariate analysis showed HCC-MELD score (hazard ratio [HR] 39.6, P < .001) and microvascular invasion (HR 2.41, P = .002) to be independent risk factors for recurrence, whereas HCC diameter (HR 1.15, P = .041), HCC-MELD (HR 15.611, P = .006), and grading (HR 2.17, P = .03) proved to be predictive factors of poor overall survival. Conclusion: Our study showed the validity of the HCC-MELD equation in the evaluation of patients undergoing LT for HCC. This score offers a reliable method to assess the risk of waiting list dropout and predict posttransplantation outcomes.",
keywords = "HCC-MELD, Hepatocellular carcinoma, Liver transplantation, Liver tumor, MELD, Milan criteria",
author = "Guerrini, {Gian Piero} and Domenico Pinelli and Elena Marini and Vittorio Corno and Michela Guizzetti and Marco Zambelli and Alessandro Aluffi and Lisa Lincini and Stefano Fagiuoli and Alessandro Lucianetti and Michele Colledan",
year = "2018",
month = "3",
day = "1",
doi = "10.1177/1526924817746686",
language = "English",
volume = "28",
pages = "63--69",
journal = "Progress in Transplantation",
issn = "1526-9248",
publisher = "InnoVision Communications",
number = "1",

}

TY - JOUR

T1 - Value of HCC-MELD score in patients with hepatocellular carcinoma undergoing liver transplantation

AU - Guerrini, Gian Piero

AU - Pinelli, Domenico

AU - Marini, Elena

AU - Corno, Vittorio

AU - Guizzetti, Michela

AU - Zambelli, Marco

AU - Aluffi, Alessandro

AU - Lincini, Lisa

AU - Fagiuoli, Stefano

AU - Lucianetti, Alessandro

AU - Colledan, Michele

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Context: Liver transplantation (LT) is considered the ideal therapy for patients with hepatocellular carcinoma (HCC) having cirrhosis but the shortage of liver donors and the risk of dropout from the wait list due to tumor progression severely limit transplantation. A new prognostic score, the HCC-model for end-stage liver disease (HCC-MELD), was developed by combining a-fetoprotein (AFP), MELD, and tumor size, to improve risk stratification of dropout in patients with HCC. Objectives: In this study, we investigated the ability of the HCC-MELD score in predicting the posttransplant for patients fulfilling Milan criteria (MC). Design: Two hundred patients with stage II tumor were retrospectively reviewed from a total of 1290 transplants performed at our institution from October 1997 through April 2015. Cox regression analysis was performed to identify the prognostic factors impacting the posttransplant survival. Results: Overall survival at 1, 5, and 10 years was 89.3%, 71.1%, and 67.2%, whereas disease-free survival was 86.4%, 66.5%, and 52.4%, respectively. Multivariate analysis showed HCC-MELD score (hazard ratio [HR] 39.6, P < .001) and microvascular invasion (HR 2.41, P = .002) to be independent risk factors for recurrence, whereas HCC diameter (HR 1.15, P = .041), HCC-MELD (HR 15.611, P = .006), and grading (HR 2.17, P = .03) proved to be predictive factors of poor overall survival. Conclusion: Our study showed the validity of the HCC-MELD equation in the evaluation of patients undergoing LT for HCC. This score offers a reliable method to assess the risk of waiting list dropout and predict posttransplantation outcomes.

AB - Context: Liver transplantation (LT) is considered the ideal therapy for patients with hepatocellular carcinoma (HCC) having cirrhosis but the shortage of liver donors and the risk of dropout from the wait list due to tumor progression severely limit transplantation. A new prognostic score, the HCC-model for end-stage liver disease (HCC-MELD), was developed by combining a-fetoprotein (AFP), MELD, and tumor size, to improve risk stratification of dropout in patients with HCC. Objectives: In this study, we investigated the ability of the HCC-MELD score in predicting the posttransplant for patients fulfilling Milan criteria (MC). Design: Two hundred patients with stage II tumor were retrospectively reviewed from a total of 1290 transplants performed at our institution from October 1997 through April 2015. Cox regression analysis was performed to identify the prognostic factors impacting the posttransplant survival. Results: Overall survival at 1, 5, and 10 years was 89.3%, 71.1%, and 67.2%, whereas disease-free survival was 86.4%, 66.5%, and 52.4%, respectively. Multivariate analysis showed HCC-MELD score (hazard ratio [HR] 39.6, P < .001) and microvascular invasion (HR 2.41, P = .002) to be independent risk factors for recurrence, whereas HCC diameter (HR 1.15, P = .041), HCC-MELD (HR 15.611, P = .006), and grading (HR 2.17, P = .03) proved to be predictive factors of poor overall survival. Conclusion: Our study showed the validity of the HCC-MELD equation in the evaluation of patients undergoing LT for HCC. This score offers a reliable method to assess the risk of waiting list dropout and predict posttransplantation outcomes.

KW - HCC-MELD

KW - Hepatocellular carcinoma

KW - Liver transplantation

KW - Liver tumor

KW - MELD

KW - Milan criteria

UR - http://www.scopus.com/inward/record.url?scp=85044928764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044928764&partnerID=8YFLogxK

U2 - 10.1177/1526924817746686

DO - 10.1177/1526924817746686

M3 - Article

AN - SCOPUS:85044928764

VL - 28

SP - 63

EP - 69

JO - Progress in Transplantation

JF - Progress in Transplantation

SN - 1526-9248

IS - 1

ER -